Dear Madam, Sir,

Under the High Patronage of Mr Emmanuel MACRON President of the French Republic, France Biotech and all the French and European health innovation ecosystem is organizing the 1st HealthTech Investor Day® in Paris (Peninsula palace), the 24th and 25th of June -

This business event aims to connect leading investors (European, American and Asian), pharmaceuticals companies and top management from French and European innovative companies in HealthTech; making the city of Paris a European place for business meetings.

This event is organized for private and listed compagnies willing to address leading investors and looking to raise funds. This event is targeting European innovative companies in HealthTech (biotech, medtech, digital-health) with a market-cap starting from €20 million (listed biotech companies), and on-going Phase 2 (private one). Regarding medtech companies, this event targets companies with CE or FDA approved product. The fees amount to €1500 for members of France Biotech and €1900 for non-members (Wondering if you are a member? Please check here

This event includes:

One-on-one meetings between innovative HealthTech companies and investors from French, European, American and Asian hedge funds, VC, banks for near and long-term investment,

One-on-one partnering meetings with international pharmaceuticals companies (for companies and investors),

Conferences and thematic panel discussions on specific topics supervised by well-known international scientific patrons and Nobel Prize winner :
- France & Europe attractivity (speakers from Business France, BPIFrance and EuropaBio);
- Economy & Finance (speakers from the Nasdaq and Euronext);
- Importance of a BD strategy in the development of a HealthTech company (BDC Lifesciences);
- Promote France’s Strengths on Health Innovation (LIR Association);
- Hot topic in Oncology : After autologous CAR-T and Anti-PD1 / anti PD-L1 … what’s next?

Glamorous event will take place along the event with special guests.

If you are interested, please complete the survey hereafter before 14th of March and we will get back to you in April regarding your application:


For more information, please do not hesitate to contact

Sophie Villedieu,
Business Manager & US Communications at France Biotech
+33 (0)6 64 27 32 25

With the assistance of Nathalie Donne in the organization